OMB
No.: 0925- XXXX Expiration
Date: XX/XX/XXXX Public
reporting burden for this collection of information is estimated to
average 30 minutes per response, including the time for reviewing
instructions, searching existing data sources, gathering and
maintaining the data needed, and completing and reviewing the
collection of information. An
agency may not conduct or sponsor, and a person is not required to
respond to, a collection of information unless it displays a
currently valid OMB control number.
Send comments regarding this burden estimate or any other aspect of
this collection of information, including suggestions for reducing
this burden to: NIH, Project Clearance Branch, 6705 Rockledge Drive,
MSC 7974, Bethesda, MD 20892-7974, ATTN: PRA (0925- XXXX). Do not
return the
completed
form to this address.
Please complete the following document and send to: [email protected].
Please include a narrative describing your study and its scientific benefit for inclusion in the Proteomic Data Commons (PDC).
Please include the following information:
Name/Identifier of Study with a brief description
Grant ID and funding source (if applicable)
IRB approval numbers (if applicable)
Scientific Point of Contact (Name, Phone, Email)
Data Manager Point of Contact (Name, Phone, Email)
Data access policy (choose one):
Open-access – no-embargo
Open-access – embargo
Cancer type(s) included in study
Number of cases included in study (please indicate if demographic and diagnosis data are available)
Information on the Proteomic Data Analysis Protocol
Type of acquisition – DDA, DIA
Experiment type – Label Free, iTRAQ, TMT, etc.
Analytical fractions – Proteome, phosphoproteome, etc.
Instrument make and model
Additional proteomic data analysis protocol including experimental design
Additional data types included in study and experimental strategies used (list all that apply and indicate target repository for additional data types such as the National Cancer Institute’s Genomic Data Commons):
Imaging
Genomics
Immunology
Clinical
Other (specify)
Amount of data (in TB, # of files)
Include description of treatment, relapse/recurrence, and/or outcome data available with this dataset (if applicable)
The overall scientific benefit of including this study in the PDC
Publications associated with this study, if any.
Time constraints on processing/loading/releasing the data to the public
Data standards used, if any.
Please attach (if available):
Data Dictionary
Biospecimen and experiment metadata
Data Model/Schema diagram indicating how collected data relates to subjects, visits, samples, etc.
File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
Author | Kim, Erika (NIH/NCI) [E] |
File Modified | 0000-00-00 |
File Created | 2022-03-17 |